GlassScriptPhysician profile
Diana E Okuniewski
NPI 1184831547
$2,837.31
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,016 · 2020: $146 · 2021: $1,675.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,426.75 | 2021 | |
| Medical Device Business Services, INC. | $872.72 | 2019 | |
| Hologic Sales and Service, LLC | $86.36 | 2019 | |
| Abbvie INC. | $74.74 | 2020-2021 | |
| Aspira Women'S Health INC | $58.84 | 2021 | |
| Ethicon US, LLC | $44.53 | 2019 | |
| Sunovion Pharmaceuticals INC. | $40.04 | 2020-2021 | |
| Allergan, INC. | $32.39 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.06 | 2020 | |
| Lundbeck LLC | $26.94 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $26.10 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $25.76 | 2020-2021 | |
| Urovant Sciences INC | $24.35 | 2021 | |
| Agile Therapeutics, INC. | $21.64 | 2021 | |
| Therapeuticsmd, INC. | $21.15 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $12.70 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.24 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Okuniewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.